AzTrials
AzTrials

Kidney StonesFANS-MiniPercNCT07332286

FANS-Assisted Mini-PCNL for Complex Renal Stones

A study testing FANS-assisted mini-percutaneous nephrolithotomy in people with Kidney Stones, run by The First Affiliated Hospital of Guangzhou Medical University at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This prospective pilot study aims to evaluate the feasibility, safety, and preliminary clinical outcomes of a novel mini-percutaneous nephrolithotomy (mini-PCNL) technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) for the treatment of complex renal stones. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Kidney Stones
What is being tested?
FANS-assisted mini-percutaneous nephrolithotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteChina
Study dates
19 Dec 2025to 30 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 to 75 years
  • Patients with renal stones measuring 2 cm or larger in maximum diameter
  • American Society of Anesthesiologists (ASA) physical status classification I-III
  • Planned to undergo mini-percutaneous nephrolithotomy
  • Able and willing to provide written informed consent

Who cannot join

  • Uncontrolled urinary tract infection at the time of surgery
  • Known bleeding tendency or coagulation disorders
  • Contraindication to general anesthesia
  • Pregnancy or breastfeeding

Trial locations and contacts

1 site in 1 country.

China1 site
  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, 510230

Other trials in China

About this study

Official title: Mini-percutaneous Nephrolithotomy With a Flexible Mini-nephroscope and a Flexible and Navigable Suction Access Sheath for Complex Renal Stones: A Prospective Pilot Study

This prospective pilot study aims to evaluate the feasibility, safety, and preliminary clinical outcomes of a novel mini-percutaneous nephrolithotomy (mini-PCNL) technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) for the treatment of complex renal stones.

Thirty consecutive patients with renal stones ≥2 cm will be prospectively enrolled. All patients will undergo FANS-assisted mini-PCNL. The primary outcome is the immediate stone-free rate assessed by non-contrast CT within 72 hours after surgery. Secondary outcomes include operative parameters, postoperative pain, complications, length of hospital stay, and quality of life.

This pilot study is designed to provide preliminary evidence supporting the feasibility and safety of FANS-assisted mini-PCNL and to inform the design of future larger-scale studies.

Read the detailed description

Conventional mini-PCNL may be limited by restricted access to anatomically challenging calyces and inefficient evacuation of stone fragments when flexible nephroscopy is required.

A novel technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) has been developed to enable flexible intrarenal navigation combined with active suction during antegrade lithotripsy.

This prospective pilot study will enroll 30 consecutive patients undergoing FANS-assisted mini-PCNL for complex renal stones. The study focuses on feasibility, safety, and preliminary clinical outcomes, including stone clearance and perioperative morbidity. The results will serve as preliminary data for future confirmatory or comparative clinical trials.

Conditions
Kidney Stones
Being tested
FANS-assisted mini-percutaneous nephrolithotomy
Keywords
PCNL, FANS, kidney stone, mini-PCNL
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FANS-assisted mini-percutaneous nephrolithotomyProcedure or surgery

    Also called Mini-PCNL using a flexible mini-nephroscope with suction access sheath

    The procedure consists of mini-percutaneous nephrolithotomy (mini-PCNL) performed with the assistance of a flexible mini-nephroscope and a flexible and navigable suction access sheath (FANS).

    Following standard percutaneous renal access and initial stone fragmentation using a rigid nephroscope, a flexible mini-nephroscope is introduced through the percutaneous tract to access calyces that are difficult to reach with rigid instruments. Holmium:YAG laser lithotripsy is then performed under flexible endoscopic visualization.

    The flexible and navigable suction access sheath allows simultaneous irrigation and adjustable negative-pressure suction, enabling continuous evacuation of stone fragments during lithotripsy. Suction strength can be regulated intraoperatively to maintain a clear endoscopic field and facilitate controlled fragment removal.

    This procedure is applied to all participants in this prospective pilot study and aims to evaluate the feasibility and safety of flexible suction

Study groups in NCT07332286
Study groupRoleWhat they receive
FANS-assisted mini-PCNLExperimentalMini-percutaneous nephrolithotomy performed using a flexible mini-nephroscope combined with a flexible and navigable suction access sheath to facilitate flexible access and active stone fragment evacuation.
Receives: Procedure: FANS-assisted mini-percutaneous nephrolithotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Immediate stone-free rate

    Absence of residual stones or fragments >2 mm detected by non-contrast CT

    Measured: Postoperative day 0 to 3

Secondary outcomes (6)
  1. Stone-free rate at 1 month

    Absence of residual stones or fragments >2 mm detected by non-contrast CT

    Measured: Postoperative day 30 (±7 days)

  2. Operative time

    Total duration of the surgical procedure measured from puncture to completion of the operation

    Measured: From skin puncture to completion of the procedure (intraoperative period)

  3. Postoperative pain score

    Postoperative pain assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable.

    Measured: Postoperative day 1

  4. Postoperative complications

    Incidence and severity of postoperative complications classified according to the Clavien-Dindo grading system

    Measured: Postoperative day 0 to 30

  5. Length of postoperative hospital stay

    Duration of hospital stay measured from completion of the procedure to hospital discharge

    Measured: Postoperative day 0 to postoperative day 14

  6. Quality of life score

    Health-related quality of life assessed using the Wisconsin Stone Quality of Life (WISQOL) questionnaire, which consists of 28 items scored on a 5-point Likert scale. Total scores range from 0 to 140, with higher scores indicating better quality of life.

    Measured: Baseline and postoperative day 30

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study start19 Dec 2025
  3. Primary completion12 Apr 2026
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07332286
Sponsor's protocol ID
ES-2025-252-02
Other IDs
ES-2025-252-02
Acronym
FANS-MiniPerc
Status last verified
Apr 2026
First submitted
19 Dec 2025
Last updated
15 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared, as this is a single-center prospective pilot study with a small sample size, and the data will be used primarily for exploratory and hypothesis-generating purposes.

Questions about this trial

What is this clinical trial studying?

A study testing FANS-assisted mini-percutaneous nephrolithotomy in people with Kidney Stones, run by The First Affiliated Hospital of Guangzhou Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Immediate stone-free rate (time frame: Postoperative day 0 to 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in